Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosella Centis

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
Archivos De Bronconeumologia|May 10, 2025
A Call to Integrate Post-TB Lung Disease into Vaccination Strategies for Chronic Respiratory DiseasesRosella Centis, Lia D'Ambrosio, Sandra J Inwentarz, et al.
Biomedicines|November 25, 2023
Brittle Asthma: Still on Board?Dina Visca, Francesco Ardesi, Rosella Centis, et al.
The European Respiratory Journal|July 2, 2013
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidenceGiovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, et al.
The European Respiratory Journal|February 2, 2016
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidenceEmanuele Pontali, Giovanni Sotgiu, Lia D'Ambrosio, et al.
Expert Review of Anti-Infective Therapy|February 4, 2015
Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosisGiovanni Sotgiu, Emanuele Pontali, Rosella Centis, et al.
Expert Review of Anti-Infective Therapy|December 4, 2012
Rediscovering high technology from the past: thoracic surgery is back on track for multidrug-resistant tuberculosisEmanuele Pontali, Alberto Matteelli, Lia D'Ambrosio, et al.
The European Respiratory Journal|January 2, 2015
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strainsGiovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, et al.
Thoracic Surgery Clinics|June 23, 2026
Post-Tuberculosis Lung Disease: The Role of Surgical ManagementIsabele Alves Chirichela, Rosella Centis, Giovanni Battista Migliori, et al.
The European Respiratory Journal|March 5, 2026
Do we need to revise the dose of isoniazid for the treatment of tuberculosis in children?Jan-Willem C Alffenaar, Shashikant Srivastava, Rosella Centis, et al.
Journal of Thoracic Disease|April 19, 2019
Recent evidence on delamanid use for rifampicin-resistant tuberculosisEmanuele Pontali, Rosella Centis, Lia D'Ambrosio, et al.
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Archivos De Bronconeumologia|May 10, 2025
A Call to Integrate Post-TB Lung Disease into Vaccination Strategies for Chronic Respiratory DiseasesRosella Centis, Lia D'Ambrosio, Sandra J Inwentarz, et al.
Biomedicines|November 25, 2023
Brittle Asthma: Still on Board?Dina Visca, Francesco Ardesi, Rosella Centis, et al.
The European Respiratory Journal|July 2, 2013
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidenceGiovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, et al.
The European Respiratory Journal|February 2, 2016
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidenceEmanuele Pontali, Giovanni Sotgiu, Lia D'Ambrosio, et al.
Expert Review of Anti-Infective Therapy|February 4, 2015
Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosisGiovanni Sotgiu, Emanuele Pontali, Rosella Centis, et al.
Expert Review of Anti-Infective Therapy|December 4, 2012
Rediscovering high technology from the past: thoracic surgery is back on track for multidrug-resistant tuberculosisEmanuele Pontali, Alberto Matteelli, Lia D'Ambrosio, et al.
The European Respiratory Journal|January 2, 2015
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strainsGiovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, et al.
Thoracic Surgery Clinics|June 23, 2026
Post-Tuberculosis Lung Disease: The Role of Surgical ManagementIsabele Alves Chirichela, Rosella Centis, Giovanni Battista Migliori, et al.
The European Respiratory Journal|March 5, 2026
Do we need to revise the dose of isoniazid for the treatment of tuberculosis in children?Jan-Willem C Alffenaar, Shashikant Srivastava, Rosella Centis, et al.
Journal of Thoracic Disease|April 19, 2019
Recent evidence on delamanid use for rifampicin-resistant tuberculosisEmanuele Pontali, Rosella Centis, Lia D'Ambrosio, et al.
Pageof 20